'MUR plus' could have a future if funded properly
Medicines use reviews (MUR) could benefit pharmacists and patients if they are funded beyond the initial consultation, a pharmacy professor has said.
While his review – which informed the Murray report into pharmacy services – concluded that there is “no evidence that MURs are clinicallly or cost effective”,
“[MURs]
Are you in favour of developing more specific MURs?